{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Use of derivatives including swaps, Compounding effect, Structured product features",
    "classification": "complex",
    "supporting_data": "The product is a leveraged ETP Securities providing 2x daily exposure to Alibaba ADR, which inherently involves leverage and daily rebalancing leading to compounding effects that retail investors find difficult to understand. It uses derivatives (swaps) as part of its synthetic replication strategy, introducing counterparty and collateral risks. The product is not capital protected and has a very high risk rating (7/7). The KID explicitly states it is 'not simple and may be difficult to understand' and is intended for sophisticated investors able to monitor frequently and understand leverage and compounding risks. Under MiFID II and ESMA guidelines, such use of leverage, synthetic replication, and embedded derivatives automatically classify the product as complex. UCITS ETFs are generally non-complex, but this product is an ETP security (not a UCITS ETF) with leverage and synthetic replication, thus complex. The presence of swaps and leverage, the synthetic replication method, and the complexity of the payoff structure (2x daily leveraged exposure) mean it fails the Article 57 criteria for non-complex instruments. Therefore, it requires an appropriateness assessment before sale to retail clients."
}